An antiserum was prepared in rabbits against an antigen obtained by density gradient
normal adult spleen, and one culture each of fetal spleen and thymus. By an indirect radioiodine-labeled antibody assay, anti-Hodgkin's disease globulin reacted with an antigen on the surface of cells from the Hodgkin's disease cultures, the quantity of which was related to the number of target cells and the amount of antibody used. This Hodgkin's disease tissue-culture antigen did not react with a rabbit antiserum against fractionated medium from a normal spleen culture, nor against noncultured Hodgkin's disease tumor tissue. The tumor specificity of the Hodgkin's disease tissue-culture antigen was assessed by a direct technique using 251-labeled anti-Hodgkin's disease globulin absorbed with either cultured Hodgkin's disease cells or with cultured normal cells. By this method the quantity of antigen on cells from Hodgkin's disease cultures was 15-to 30 -fold greater than that on cells from normal cultures.
The Hodgkin's disease tissue-culture antigen is intimately associated with the propagation of the tumor in monolayer cultures, but its identity has not been established: it could be a viral component, a tumor or fetal antigen, or a -normal tissue constituent.
An antigen has been demonstrated recently in serially passaged monolayer cultures derived from spleens involved by Hodgkin's disease (HD). The antigen was detected with a rabbit antiserum prepared against material recovered from the culture medium by sedimentation in an isopycnic sucrose gradient. Reaction of the antigen and antiserum was first demonstrated by agar gel diffusion and immunoelectrophoresis (1) .
In the studies described in the preceding paper, the antigen was observed by fluorescence microscopy in the cell membrane and cytoplasm of cells from Hodgkin's disease cultures, but not in noncultured Hodgkin's disease tumor tissue (2) . Although experiments with the fluorescent microscope have clarified the cellular localization of the Hodgkin's disease tissue-culture antigen, the evidence regarding the tumor specificity of the antigen was inconclusive; i.e., a quantitative difference in an antigen common to Hodgkin's disease and 
MATERIALS AND METHODS
Monolayer Culture Cells. Ten culture lines derived from pathologically positive spleens of patients with Hodgkin's disease, eight cultures of normal adult spleen, and one culture line each of fetal thymus and spleen were used as target cells for the radioiodine-labeled antibody assays. The preparation, maintenance, and cytological features of these serially passaged, long-term monolayer cultures have been described (1, 2) .
Antisera. An anti-HD antiserum was prepared by immunizing rabbits with material of specific gravity 1.15-1.21 obtained by density gradient sedimentation of centrifuged medium from Hodgkin's disease cultures. The globulin fraction of the antiserum was absorbed with noncultured normal spleen cells, fetal-calf serum, and type A positive human erythrocytes. Details of the preparation and absorption of anti-HD globulin have been published (1) . Two antisera used as controls were prepared by immunizing rabbits with medium from a normal spleen culture line that had been fractionated by sedimentation gradient centrifugation, and with minced tissue from a noncultured Hodgkin's disease lymph node. The globulin fractions of these antisera had been used as controls in the gel diffusion (1) and fluorescent microscopy experiments (2) .
Indirect Radioiodine-Labeled Antibody Experiments. 125I-Conjugated antiserum against rabbit immunoglobulin was prepared as follows. Goat antiserum to rabbit immunoglobulin (Meloy Laboratories, Springfield, Va.) was precipitated three times with 35% (w/v) ammonium sulfate, and the globulin fraction thereby obtained was dialyzed against 50 mM phosphate buffer, pH 7.0. The immunoglobulin concentration was adjusted to 2 mg/ml by the addition of phosphate buffer.
Immunoglobulin (200 Mg) was then reacted with 10 mCi of carrier-free 125I (New England Nuclear Corp.) by the chloramine-T method (3), and dialyzed against phosphate-buffered saline, pH 7.4, to remove unbound iodine. Seventy-six percent of the radioiodine was bound to the immunoglobulin, 99% of which was precipitable in 10% trichloroacetic acid. The specific activity of the radioiodine-labeled antibody to rabbit immunoglobulin was 38 /ACi/Mug of immunoglobulin.
In the absence of chloramine-T, less than 1% of the 125I was conjugated to the immunoglobulin. (2) and for the indirect 12-labeled antibody assay above, after which two additional absorptions were carried out with cells from either Hodgkin's disease or normal spleen cultures.
The direct radioiodine-labeled antibody experiments were done as described for the indirect assay except that 100 MAl of 125-labeled anti-HD globulin was added to tissue-culture target cells, and the number of washes was reduced from 11 to 7 since there was only one incubation of cells with antibody in the direct test. RESULTS
The Indirect Assay. Results (Fig. 1) . The 125I cpm for target cells from Hodgkin's disease and normal cultures incubated with a 1: 20 dilution of normal rabbit globulin were similar and ranged from 75 to 980. The 125I cpm for target cells from normal cultures incubated with anti-HD globulin were slightly, but consistently, greater than those observed when the cells from normal cultures were incubated with similarly diluted normal rabbit globulin (Fig. 1) .
The effect of the concentration of anti-HD globulin on the 125J cpm is plotted in Fig. 2 Fig. 1 , the '1I cpm for target cells from normal cultures incubated with anti-HD globulin were slightly greater than those observed when the normal cells were incubated with similarly diluted normal rabbit globulin (Fig. 2) .
The reaction of anti-HD globulin with tissue-culture target cells was then compared with that of two control antisera (antiserum prepared against fractionated medium from a normal spleen culture, and another prepared against non- Brief incubation of washed target cells with various dilutions of trypsin prior to incubation with anti-HD antiserum globulin had no effect on the subsequent binding of 125I-labeled antibody to rabbit immunoglobulin (4 for each dilution of 151-labeled anti-HD globulin (expressed as mean of the difference, and the standard deviation of the difference).
t Ratio of the mean antigen-specific counts for Hodgkin's disease culture cells to the mean antigen-specific counts for normal culture cells.
( Table 2 ). The quantity of antigen per 106 target cells was calculated as follows: antigen-specific 125I cpm/106 cells from Hodgkin's disease for normal cultures = (cpm/106 cells incubated with l25I-labeled anti-HD globulin absorbed with cells from normal spleen cultures) minus (cpm/106 cells incubated with '2I-labeled anti-HD globulin absorbed with cells from Hodgkin's disease cultures). The antigen-specific counts for target cells from both Hodgkin's disease and normal cultures, therefore, were calculated in terms of the difference in the reactivity of l25I-labeled anti-HD globulin absorbed with cells from two different tissue culture sources. The ratio of the quantity of antigen on cells from Hodgkin's disease cultures compared with that on cells from normal cultures varied from 14:1 to 30:1, depending upon the dilution of 1251I-labeled anti-HD globulin used. For example, at an antibody dilution of 1: 40, the mean of the antigen-specific 125I cpm per 106 target cells from the Hodgkin's disease cultures was 3897 i 980. At the same antibody dilution, the mean antigen-specific 1251I cpm per 106 normal target cells was 174 4 48. The ratio of these two mean values was 23:1, indicating that the quantity of antigen on cells from Hodgkin's disease cultures was 23-fold greater than the quantity of antigen on cells from normal cultures. At an antibody dilution of 1:100, the ratio was 30:1, whereas at antibody dilutions of 1: 200 and 1: 300, the ratios were 19:1 and 14:1, respectively (Table 2) .
DISCUSSION
In the present investigation the indirect and direct isotopic antibody techniques were used to study the reaction of an antiserum with target cells from Hodgkin's disease and normal spleen and thymus cultures. The antiserum was prepared in rabbits against an antigen isolated by density gradient sedimentation of the medium from Hodgkin's disease monolayer cultures. In other systems (5) (6) (7) (8) , the isotopic antibody method has proven to be a sensitive and quantitative assay of cell surface antigens.
The anti-HD globulin reacted with an antigen on the surface of Hodgkin's disease tissue-culture cells as measured with the indirect technique; radioiodinated goat antibody to rabbit immunoglobulin was bound to the cell surface in the presence of anti-HD globulin. The quantity of bound antibody varied with the number of target cells from Hodgkin's disease cultures ( Fig. 1) and with the dilution of anti-HD globulin (Fig.  2) Since antiserum to the Hodgkin's disease tissue-culture antigen consistently displayed a low level of reactivity with cultured normal spleen cells, the specificity of the Hodgkin's disease antigen, on the basis of the indirect radioiodinated antibody experiments, remains in doubt. This reactivity could not be attributed to nonspecific adherence of rabbit globulin to the surface of normal cells because the binding of anti-HD globulin to normal target cells was slightly greater than that of normal rabbit globulin (Figs. 1 and 2 , Table 1 ). Moreover, "unmasking" of the antigen (4) was not observed after gentle trypsinization of target cells from normal cultures.
The direct isotopic antibody assay was designed to permit more precise measurement of the quantity of "tumor" antigen on target cells from Hodgkin's disease and normal cultures, and to take into account any residual reactivity of anti-HD globulin with normal cellular antigens which might result from incomplete absorption of the antibody. By this assay, the ratio of the quantity of antigen on the surface of cells from Hodgkin's disease cultures to the quantity of antigen on cells from normal monolayers ranged from 14:1 to 30:1, depending on the dilution of iodinated anti-HD globulin used ( Table 2 ). The small amount of reactivity with target cells from normal cultures suggests the presence of the antigen on normal cells. This could be explained by differences in the cell populations comprising the normal and the Hodgkin's disease monolayers, a possibility suggested by the different morphologic appearances of the respective cultures (2) . Alternatively, the small amount of reactivity of normal spleen cultures may reflect only background "noise" inherent in the highly sensitive direct isotopic method. Finally, despite absorption of anti-HD globulin with both noncultured and cultured spleen cells, it remains possible that reactivity with a normal component has not been completely removed and still contaminates the antibody. The Hodgkin's disease tissue-culture antigen could be a virus component. The antigen banded in the isopycnic density sedimentation gradient at specific gravity 1.15-1.21 (1) may be present in small amounts or in a cryptic state in cultured normal adult and fetal cells, and was demonstrable in cells carried in culture but not in noncultured tumor tissue; all data consistent with a hypothetical virogene (9) (10) (11) (12) (13) (14) . However, we have not found the Hodgkin's disease tissue-culture antigen to be immunologically related to several known oncogenic viruses, including the Rauscher murine leukemia, the EpsteinBarr, the herpes simplex, the RD-114, and the avian myeloblastosis viruses (1). Moreover, cell-free extracts from several Hodgkin's disease culture lines have not induced the formation of the antigen in normal cells carried in culture, and addition of 5-iododeoxyuridine and dimethylsulfoxide, or the administration of ultraviolet light [procedures to increase the amount of a viral antigen (15, 16) ] did not increase the titer of antigen in Hodgkin's disease cultures as measured with the iodinated antibody technique (unpublished). Therefore, the evidence linking the Hodgkin's disease tissue culture with an oncogenic virus remains inconclusive: the demonstration of such a virus will require other means.
